Media coverage about Endo International plc – (NASDAQ:ENDP) has trended somewhat positive recently, AlphaOne Sentiment reports. The research group, a subsidiary of Accern, identifies positive and negative press coverage by reviewing more than twenty million blog and news sources. AlphaOne ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Endo International plc – earned a daily sentiment score of 0.08 on AlphaOne’s scale. AlphaOne also assigned headlines about the company an impact score of 64 out of 100, meaning that recent press coverage is somewhat likely to have an impact on the company’s share price in the near future.
These are some of the news headlines that may have impacted AlphaOne’s scoring:
- Equities Analysts Offer Predictions for Endo International plc -‘s Q1 2017 Earnings (ENDP) (americanbankingnews.com)
- Stocks in Focus: ING Groep NV (ADR) (NYSE:ING), Endo International plc – Ordinary Shares (NASDAQ:ENDP), New … – Wall Street Times (press release) (wallstreetnews24.com)
- Biotech Movers: Organovo, Endo, Omeros (finance.yahoo.com)
- Endo International plc – (ENDP) Stock Rating Reaffirmed by Canaccord Genuity (americanbankingnews.com)
- Endo International plc – (ENDP) Given “Hold” Rating at Canaccord Genuity (semiconductors.einnews.com)
Several analysts have recently commented on the stock. Canaccord Genuity restated a “hold” rating and issued a $14.00 target price on shares of Endo International plc – in a research note on Monday. Mizuho restated a “buy” rating and issued a $18.00 target price (up previously from $17.00) on shares of Endo International plc – in a research note on Thursday, April 13th. Royal Bank of Canada set a $15.00 target price on shares of Endo International plc – and gave the stock a “hold” rating in a research note on Saturday, April 8th. Leerink Swann restated a “market perform” rating on shares of Endo International plc – in a research note on Monday, March 20th. Finally, JMP Securities restated an “outperform” rating and issued a $20.00 target price on shares of Endo International plc – in a research note on Wednesday, March 15th. Thirteen analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Endo International plc – has an average rating of “Hold” and an average price target of $20.72.
Endo International plc – (NASDAQ:ENDP) traded down 1.81% during trading on Friday, reaching $10.29. 5,835,433 shares of the company’s stock traded hands. The stock’s market capitalization is $2.29 billion. Endo International plc – has a 12 month low of $9.70 and a 12 month high of $35.34. The company has a 50-day moving average of $10.84 and a 200 day moving average of $14.65.
Endo International plc – (NASDAQ:ENDP) last issued its earnings results on Tuesday, February 28th. The company reported $1.77 earnings per share for the quarter, beating analysts’ consensus estimates of $1.63 by $0.14. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.17 billion. Endo International plc – had a positive return on equity of 15.95% and a negative net margin of 3.32%. The firm’s quarterly revenue was up 15.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.36 EPS. On average, equities research analysts expect that Endo International plc – will post $3.60 earnings per share for the current fiscal year.
In other news, Director Nancy J. Hutson sold 5,325 shares of the company’s stock in a transaction dated Thursday, March 9th. The stock was sold at an average price of $10.82, for a total value of $57,616.50. The sale was disclosed in a filing with the SEC, which is accessible through this link. 0.70% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “Somewhat Favorable Media Coverage Somewhat Likely to Impact Endo International plc – (ENDP) Stock Price” was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://www.themarketsdaily.com/2017/04/21/somewhat-favorable-media-coverage-somewhat-likely-to-impact-endo-international-plc-endp-stock-price.html.
About Endo International plc –
Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.
Receive News & Ratings for Endo International plc - Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International plc - and related companies with MarketBeat.com's FREE daily email newsletter.